(Q63835278)

English

Pimecrolimus and Epidermal Barrier Function

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

Role for Pimecrolimus in Restoring Skin Barrier Function and Normalizing Epidermal Lipid Content and Differentiation in Atopic Epidermis: a Randomized, Intra-patient, Double-blind (Right/Left Arm) Study in Adults With Atopic Dermatitis Treated With 1 % Pimecrolimus Cream and 0.1 % Betamethasone Cream as Treatment Control Twice Daily for 3 Weeks (English)
0 references
0 references
0 references
0 references
0 references
March 2005
0 references
15
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit